169 related articles for article (PubMed ID: 7926571)
21. Early invasive adenocarcinoma of the uterine cervix: criteria for nonradical surgical treatment.
Kasamatsu T; Okada S; Tsuda H; Shiromizu K; Yamada T; Tsunematsu R; Ohmi K
Gynecol Oncol; 2002 May; 85(2):327-32. PubMed ID: 11972396
[TBL] [Abstract][Full Text] [Related]
22. Prediction of residual neoplasia based on histopathology and margin status of conization specimens.
Chang DY; Cheng WF; Torng PL; Chen RJ; Huang SC
Gynecol Oncol; 1996 Oct; 63(1):53-6. PubMed ID: 8898168
[TBL] [Abstract][Full Text] [Related]
23. Early invasive carcinoma of the cervix.
Jones WB; Mercer GO; Lewis JL; Rubin SC; Hoskins WJ
Gynecol Oncol; 1993 Oct; 51(1):26-32. PubMed ID: 8244170
[TBL] [Abstract][Full Text] [Related]
24. [Problems in the indication for hysterectomy post conization].
Bader G; Neumann HG
Zentralbl Gynakol; 1975; 97(8):463-6. PubMed ID: 1220457
[TBL] [Abstract][Full Text] [Related]
25. Conization as treatment of carcinoma in situ of the uterine cervix.
Ahlgren M; Ingemarsson I; Lindberg LG; Nordqvist RB
Obstet Gynecol; 1975 Aug; 46(2):135-9. PubMed ID: 1153146
[TBL] [Abstract][Full Text] [Related]
26. [The frequency and clinical significance of incomplete removal of epithelial lesions on the cervix uteri by conisation (author's transl)].
Kraus H; Schuhmann R; Breinl H; Piroth H
Geburtshilfe Frauenheilkd; 1976 May; 36(5):439-44. PubMed ID: 1278664
[TBL] [Abstract][Full Text] [Related]
27. Total laparoscopic radical hysterectomy (type II-III) with pelvic lymphadenectomy in early invasive cervical cancer.
Gil-Moreno A; Puig O; Pérez-Benavente MA; Díaz B; Vergés R; De la Torre J; Martínez-Palones JM; Xercavins J
J Minim Invasive Gynecol; 2005; 12(2):113-20. PubMed ID: 15904613
[TBL] [Abstract][Full Text] [Related]
28. Recurrent invasive adenocarcinoma after hysterectomy for cervical adenocarcinoma in situ.
Krivak TC; Retherford B; Voskuil S; Rose GS; Alagoz T
Gynecol Oncol; 2000 May; 77(2):334-5. PubMed ID: 10785491
[TBL] [Abstract][Full Text] [Related]
29. Conservative surgical treatment in cervical cancer with 3 to 5 mm stromal invasion in the absence of confluent invasion and lymph-vascular space involvement.
Yaegashi N; Sato S; Inoue Y; Noda K; Yajima A
Gynecol Oncol; 1994 Sep; 54(3):333-7. PubMed ID: 8088610
[TBL] [Abstract][Full Text] [Related]
30. [Results of the conservative management of carcinoma in situ of the uterine cervix by conization (author's transl)].
Holzer E
Geburtshilfe Frauenheilkd; 1976 Aug; 36(8):630-9. PubMed ID: 976703
[TBL] [Abstract][Full Text] [Related]
31. Vaginal semiradical hysterectomy: a new operative procedure for microinvasive carcinoma of the cervix.
Kudo R; Ito E; Kusanagi T; Hashimoto M
Obstet Gynecol; 1984 Dec; 64(6):810-5. PubMed ID: 6504424
[TBL] [Abstract][Full Text] [Related]
32. [Study of 68 microinvasive carcinomas of the cervix uteri].
Brémond A; Frappart L; Migaud C
J Gynecol Obstet Biol Reprod (Paris); 1985; 14(8):1025-31. PubMed ID: 3833901
[TBL] [Abstract][Full Text] [Related]
33. Changes in the demographics and perioperative care of stage IA(2)/IB(1) cervical cancer over the past 16 years.
Covens A; Rosen B; Murphy J; Laframboise S; DePetrillo AD; Lickrish G; Colgan T; Chapman W; Shaw P
Gynecol Oncol; 2001 May; 81(2):133-7. PubMed ID: 11330939
[TBL] [Abstract][Full Text] [Related]
34. [Prognostic factors in stage Ia-IIb invasive cervix cancer after radical hysterectomy with special reference to stroma reaction].
Reinthaller A; Tatra G; Breitenecker G; Janisch H
Geburtshilfe Frauenheilkd; 1991 Oct; 51(10):809-13. PubMed ID: 1761169
[TBL] [Abstract][Full Text] [Related]
35. Clinical outcome of patients with FIGO stage IA2 squamous cell carcinoma of the uterine cervix.
Smrkolj S; Pogačnik RK; Slabe N; Rakar S
Gynecol Oncol; 2012 Jan; 124(1):68-71. PubMed ID: 22014630
[TBL] [Abstract][Full Text] [Related]
36. The presence of residual disease in the cervix of hysterectomy specimens from women in whom there has been a previous diagnosis of cervical carcinoma.
Heatley MK
J Obstet Gynaecol; 2002 Jan; 22(1):45-7. PubMed ID: 12521728
[TBL] [Abstract][Full Text] [Related]
37. Clinicopathological variables predictive of clinical outcome in patients with FIGO stage Ib2-IIb cervical cancer treated with cisplatin-based neoadjuvant chemotherapy followed by radical hysterectomy.
Gadducci A; Teti G; Barsotti C; Tana R; Fanucchi A; Orlandini C; Fabrini MG; Genazzani AR
Anticancer Res; 2010 Jan; 30(1):201-8. PubMed ID: 20150636
[TBL] [Abstract][Full Text] [Related]
38. [Recurrence following staged treatment of cervical cancer in stage Ia].
Lotze W; Richter P
Zentralbl Gynakol; 1985; 107(7):411-7. PubMed ID: 4002927
[TBL] [Abstract][Full Text] [Related]
39. [Modern treatment of early-stage cervical cancer].
Ivanov S; Tiufekchieva E
Akush Ginekol (Sofiia); 2006; 45(7):3-5. PubMed ID: 17489161
[TBL] [Abstract][Full Text] [Related]
40. Laparoscopic surgical staging in cervical cancer--preliminary experience among Chinese.
Chu KK; Chang SD; Chen FP; Soong YK
Gynecol Oncol; 1997 Jan; 64(1):49-53. PubMed ID: 8995546
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
